| Bowling Family Medical Clinic | |
|
1369a George Wallace Hwy Russellville AL 35654-3281 | |
| (256) 503-3081 | |
| Not Available |
| Full Name | Bowling Family Medical Clinic |
|---|---|
| Speciality | Family Medicine |
| Location | 1369a George Wallace Hwy, Russellville, Alabama |
| Authorized Official Name and Position | Kevin Paul Bowling (NURSE PRACTITIONER) |
| Authorized Official Contact | 2565033081 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Bowling Family Medical Clinic 1369a George Wallace Hwy Russellville AL 35654-3281 Ph: (256) 503-3081 | Bowling Family Medical Clinic 1369a George Wallace Hwy Russellville AL 35654-3281 Ph: (256) 503-3081 |
| NPI Number | 1750942140 |
|---|---|
| Provider Enumeration Date | 06/26/2019 |
| Last Update Date | 10/30/2020 |
| Medicare PECOS PAC ID | 3173955150 |
|---|---|
| Medicare Enrollment ID | O20191112003462 |
News Archive
Connecticut lawmakers approved a budget Monday that moves about $6 billion in federal Medicaid dollars out of the budget. The budget also cuts some hospital funding.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.
Roche and Precision System Science, Co., Ltd (PSS) today announced the signing of an exclusive agreement to develop and manufacture a fully automated emulsion PCR instrument for Roche's portfolio of next-generation sequencing platforms. It is intended to support Roche's GS Junior and GS FLX+ systems as well as the sequencing platforms that Roche is currently developing.
Molina Healthcare, a major insurer in Medicaid and state exchanges across the country, has shut down its online patient portal as it investigates a potential data breach that may have exposed sensitive medical information.
In a major medical breakthrough, cancer expert Prof Ian Frazer is on the verge of developing a vaccine against skin cancer within a year. The former ‘Australian of the Year' and creator of the world's first cervical cancer vaccine, Gardasil, has developed a world-first strategy to combat the insidious disease that affects two out of three Australians.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750942140 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Josiah C Daily |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1285837377 PECOS PAC ID: 6800931056 Enrollment ID: I20100226000797 |
News Archive
Connecticut lawmakers approved a budget Monday that moves about $6 billion in federal Medicaid dollars out of the budget. The budget also cuts some hospital funding.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.
Roche and Precision System Science, Co., Ltd (PSS) today announced the signing of an exclusive agreement to develop and manufacture a fully automated emulsion PCR instrument for Roche's portfolio of next-generation sequencing platforms. It is intended to support Roche's GS Junior and GS FLX+ systems as well as the sequencing platforms that Roche is currently developing.
Molina Healthcare, a major insurer in Medicaid and state exchanges across the country, has shut down its online patient portal as it investigates a potential data breach that may have exposed sensitive medical information.
In a major medical breakthrough, cancer expert Prof Ian Frazer is on the verge of developing a vaccine against skin cancer within a year. The former ‘Australian of the Year' and creator of the world's first cervical cancer vaccine, Gardasil, has developed a world-first strategy to combat the insidious disease that affects two out of three Australians.
› Verified 4 days ago
| Provider Name | Kevin Paul Bowling |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1639609720 PECOS PAC ID: 6406113430 Enrollment ID: I20171130000154 |
News Archive
Connecticut lawmakers approved a budget Monday that moves about $6 billion in federal Medicaid dollars out of the budget. The budget also cuts some hospital funding.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.
Roche and Precision System Science, Co., Ltd (PSS) today announced the signing of an exclusive agreement to develop and manufacture a fully automated emulsion PCR instrument for Roche's portfolio of next-generation sequencing platforms. It is intended to support Roche's GS Junior and GS FLX+ systems as well as the sequencing platforms that Roche is currently developing.
Molina Healthcare, a major insurer in Medicaid and state exchanges across the country, has shut down its online patient portal as it investigates a potential data breach that may have exposed sensitive medical information.
In a major medical breakthrough, cancer expert Prof Ian Frazer is on the verge of developing a vaccine against skin cancer within a year. The former ‘Australian of the Year' and creator of the world's first cervical cancer vaccine, Gardasil, has developed a world-first strategy to combat the insidious disease that affects two out of three Australians.
› Verified 4 days ago
| Provider Name | Callie Christiann Bowling |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1366904187 PECOS PAC ID: 6507760899 Enrollment ID: I20190702002226 |
News Archive
Connecticut lawmakers approved a budget Monday that moves about $6 billion in federal Medicaid dollars out of the budget. The budget also cuts some hospital funding.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.
Roche and Precision System Science, Co., Ltd (PSS) today announced the signing of an exclusive agreement to develop and manufacture a fully automated emulsion PCR instrument for Roche's portfolio of next-generation sequencing platforms. It is intended to support Roche's GS Junior and GS FLX+ systems as well as the sequencing platforms that Roche is currently developing.
Molina Healthcare, a major insurer in Medicaid and state exchanges across the country, has shut down its online patient portal as it investigates a potential data breach that may have exposed sensitive medical information.
In a major medical breakthrough, cancer expert Prof Ian Frazer is on the verge of developing a vaccine against skin cancer within a year. The former ‘Australian of the Year' and creator of the world's first cervical cancer vaccine, Gardasil, has developed a world-first strategy to combat the insidious disease that affects two out of three Australians.
› Verified 4 days ago
| Provider Name | Chrisy Dawn Gambrell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1487246393 PECOS PAC ID: 1456767201 Enrollment ID: I20210303000966 |
News Archive
Connecticut lawmakers approved a budget Monday that moves about $6 billion in federal Medicaid dollars out of the budget. The budget also cuts some hospital funding.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.
Roche and Precision System Science, Co., Ltd (PSS) today announced the signing of an exclusive agreement to develop and manufacture a fully automated emulsion PCR instrument for Roche's portfolio of next-generation sequencing platforms. It is intended to support Roche's GS Junior and GS FLX+ systems as well as the sequencing platforms that Roche is currently developing.
Molina Healthcare, a major insurer in Medicaid and state exchanges across the country, has shut down its online patient portal as it investigates a potential data breach that may have exposed sensitive medical information.
In a major medical breakthrough, cancer expert Prof Ian Frazer is on the verge of developing a vaccine against skin cancer within a year. The former ‘Australian of the Year' and creator of the world's first cervical cancer vaccine, Gardasil, has developed a world-first strategy to combat the insidious disease that affects two out of three Australians.
› Verified 4 days ago
| Provider Name | Molly Cox |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952008633 PECOS PAC ID: 0547626509 Enrollment ID: I20231110002417 |
News Archive
Connecticut lawmakers approved a budget Monday that moves about $6 billion in federal Medicaid dollars out of the budget. The budget also cuts some hospital funding.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.
Roche and Precision System Science, Co., Ltd (PSS) today announced the signing of an exclusive agreement to develop and manufacture a fully automated emulsion PCR instrument for Roche's portfolio of next-generation sequencing platforms. It is intended to support Roche's GS Junior and GS FLX+ systems as well as the sequencing platforms that Roche is currently developing.
Molina Healthcare, a major insurer in Medicaid and state exchanges across the country, has shut down its online patient portal as it investigates a potential data breach that may have exposed sensitive medical information.
In a major medical breakthrough, cancer expert Prof Ian Frazer is on the verge of developing a vaccine against skin cancer within a year. The former ‘Australian of the Year' and creator of the world's first cervical cancer vaccine, Gardasil, has developed a world-first strategy to combat the insidious disease that affects two out of three Australians.
› Verified 4 days ago
News Archive
Connecticut lawmakers approved a budget Monday that moves about $6 billion in federal Medicaid dollars out of the budget. The budget also cuts some hospital funding.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.
Roche and Precision System Science, Co., Ltd (PSS) today announced the signing of an exclusive agreement to develop and manufacture a fully automated emulsion PCR instrument for Roche's portfolio of next-generation sequencing platforms. It is intended to support Roche's GS Junior and GS FLX+ systems as well as the sequencing platforms that Roche is currently developing.
Molina Healthcare, a major insurer in Medicaid and state exchanges across the country, has shut down its online patient portal as it investigates a potential data breach that may have exposed sensitive medical information.
In a major medical breakthrough, cancer expert Prof Ian Frazer is on the verge of developing a vaccine against skin cancer within a year. The former ‘Australian of the Year' and creator of the world's first cervical cancer vaccine, Gardasil, has developed a world-first strategy to combat the insidious disease that affects two out of three Australians.
› Verified 4 days ago
Russellville Hospital Medical Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 15225 Highway 43 Ste I, Russellville, AL 35653 Phone: 256-331-2700 Fax: 256-331-2777 | |
Lakeland Cardiology & Internal Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 531 Gandy St Ne, Russellville, AL 35653 Phone: 205-485-7280 Fax: 205-485-7391 | |
Russellville Internal Medicine Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 535 Gandy St Ne, Russellville, AL 35653 Phone: 256-332-1120 Fax: 256-332-1198 | |
Almirol Internal Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 15225 Highway 43, Suite G, Russellville, AL 35653 Phone: 256-331-1900 Fax: 256-331-1901 | |
John R Almirol M.d. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 201 Jackson Ave S, Russellville, AL 35653 Phone: 256-332-3321 Fax: 256-331-0720 | |
Dba Lakeshore Pediatric Rural Health Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 603 Gandy St Ne, Russellville, AL 35653 Phone: 256-331-5055 Fax: 256-460-4647 | |
Family Medicine Of Russellville Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 605 Gandy St Ne, Russellville, AL 35653 Phone: 256-332-8969 Fax: 256-332-8353 |